CellaVision AB (C26) Stock Statistics & Valuation Metrics

CellaVision AB has a market cap or net worth of €422.82M. The enterprise value is ―.

CellaVision AB has 23,851,547 shares outstanding. The number of shares has decreased by -2.65% in one year.

CellaVision AB’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 15.40%.

The current PE Ratio of CellaVision AB is 36.86. CellaVision AB’s PEG ratio is 3.75.

In the last 12 months, CellaVision AB had revenue of 723.22M and earned 140.72M in profits. Earnings per share was 5.90.

In the last 12 months, operating cash flow was 188.51M and capital expenditures -122.25M, giving a free cash flow of 66.26M billion.

CellaVision AB pays an annual dividend of €0.23, resulting in a dividend yield of 1.25%

CellaVision AB upcoming earnings date is Jul 18, 2025, TBA Not Confirmed.

CellaVision AB as a current ratio of 3.72, with Debt / Equity ratio of 2.74%

In the past 12 months, CellaVision AB has paid 36.14M in taxes.

CellaVision AB EV to EBITDA ratio is 23.05, with an EV/FCF ratio of 41.97.

CellaVision AB has €182.32M in cash and marketable securities with kr22.96M in debt, giving a net cash position of -€159.36M billion.

Gross margin is 68.48%, with operating margin of 24.57%, and net profit margin of 19.46%.

The average price target for CellaVision AB is ―, which is 11.43% higher than the current price. The consensus rating is ―